News and Community

Ai Drug Discovery, Brain-penetrant Therapy, Healthcare Technology, Iam217, Iambic, Kif18a Inhibitor, Solid Tumors, Triple-negative Breast Cancer

October 6, 2026

Iambic Announces IND Submission for IAM217, a Potentially Brain-Penetrant KIF18A Inhibitor and Second AI-Discovered Candidate

Aft-70 Navigate, Alliance Foundation Trials, Breast Cancer Clinical Trials, Cdk4/6 Inhibitors, Giredestrant, Healthcare Technology, Mrd-guided Therapy, Signatera

October 6, 2026

Alliance Foundation Trials and Natera Launch AFT-70 NAVIGATE, a Global Phase III Trial Evaluating SERD Therapy in Breast Cancer

Aptar Pharma, Drug Delivery, Elastomer Components, Healthcare Technology, Injectable Therapies, Pharmaceutical Packaging, Premia Precision

October 6, 2026

Aptar Pharma Introduces Premia™ Precision, Setting a New Quality Standard for Demanding Injectable Therapies